1. Home
  2. AEHL vs LEXX Comparison

AEHL vs LEXX Comparison

Compare AEHL & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEHL
  • LEXX
  • Stock Information
  • Founded
  • AEHL 1993
  • LEXX 2004
  • Country
  • AEHL China
  • LEXX Canada
  • Employees
  • AEHL N/A
  • LEXX N/A
  • Industry
  • AEHL Building Materials
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AEHL Industrials
  • LEXX Health Care
  • Exchange
  • AEHL Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • AEHL 13.9M
  • LEXX 16.5M
  • IPO Year
  • AEHL 2007
  • LEXX N/A
  • Fundamental
  • Price
  • AEHL $2.89
  • LEXX $0.82
  • Analyst Decision
  • AEHL
  • LEXX Strong Buy
  • Analyst Count
  • AEHL 0
  • LEXX 1
  • Target Price
  • AEHL N/A
  • LEXX $4.00
  • AVG Volume (30 Days)
  • AEHL 652.6K
  • LEXX 202.2K
  • Earning Date
  • AEHL 09-29-2025
  • LEXX 07-14-2025
  • Dividend Yield
  • AEHL N/A
  • LEXX N/A
  • EPS Growth
  • AEHL N/A
  • LEXX N/A
  • EPS
  • AEHL N/A
  • LEXX N/A
  • Revenue
  • AEHL $98,773,000.00
  • LEXX $615,923.00
  • Revenue This Year
  • AEHL N/A
  • LEXX $38.85
  • Revenue Next Year
  • AEHL N/A
  • LEXX $24.13
  • P/E Ratio
  • AEHL N/A
  • LEXX N/A
  • Revenue Growth
  • AEHL 36.99
  • LEXX 49.85
  • 52 Week Low
  • AEHL $1.79
  • LEXX $0.78
  • 52 Week High
  • AEHL $167.60
  • LEXX $4.38
  • Technical
  • Relative Strength Index (RSI)
  • AEHL 34.95
  • LEXX 40.49
  • Support Level
  • AEHL $1.80
  • LEXX $0.78
  • Resistance Level
  • AEHL $2.50
  • LEXX $0.85
  • Average True Range (ATR)
  • AEHL 0.73
  • LEXX 0.06
  • MACD
  • AEHL -0.19
  • LEXX -0.01
  • Stochastic Oscillator
  • AEHL 11.63
  • LEXX 19.00

About AEHL Antelope Enterprise Holdings Limited

Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: